Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1547330

This article is part of the Research Topic Immune-genetic dynamics in disease progression and therapeutic strategies View all articles

Differential neuropilin isoform expressions highlight plasticity in macrophages in the heterogenous TME through in-silico profiling

Provisionally accepted
HYUN-JEE HAN HYUN-JEE HAN Marcos Rubio-Alarcon Marcos Rubio-Alarcon *Thomas Allen Thomas Allen *Sunwoo Lee Sunwoo Lee *Taufiq Rahman Taufiq Rahman *
  • University of Cambridge, Cambridge, United Kingdom

The final, formatted version of the article will be published soon.

    The nuanced roles of neuropilin (NRP) isoforms, NRP1 and NRP2, have attracted considerable scientific interest regarding cancer progression. Their differential expressions across various cancer types are specific to NRP isoforms which are shown in a cancer type-dependent manner. It accounts for the different mechanisms involved, driven by a co-expression of gene-sets associated with overexpressed NRP1 or NRP2. Through single-cell sequencing analyses, we examined gene expressions and cellular heterogeneity within the cancers revealing heightened NRP1 expression in clear cell Renal Cell Carcinoma (ccRCC) and NRP2 in skin cutaneous melanoma (SKCM), specifically both amongst tumour-associated macrophages (TAMs). Both NRP1 + and NRP2 + TAMs exhibit an M2-like polarisation with pro-tumorigenic activities, such as immune suppression and ECM degradation.Notably, through DEGA we discovered previously uncharacterised NRP-related subpopulations for the disaparate cancer types. While the upregulation of gene-sets associated with NRP1 was identified to drive angiogenesis and tumour progression through VEGF signalling, NRP2 showed dual functionality in the TME-dependent manner, which has been illustrated through co-enrichment of the various expected gene signatures in NRP1 + and NRP2 + TAMs, highlighting their distinct roles in regulating macrophage plasticity, tumour invasion, and metastasis. This study aims to establish a foundation for future research, leading to biological experiments with focused gene-sets derived from our findings. This approach can contribute to the development of immunomodulatory strategies targeting specific NRP isoforms in macrophages, tailored to individual cancer types and abnormal expressions of those gene markers, potentially offering a more effective therapeutic approach compared to broad-spectrum NRP inhibition strategies.

    Keywords: Neuropilin (NRP), macrophage, single cell profiling, TME (tumor microenvironment), ccRCC, SKCM

    Received: 18 Dec 2024; Accepted: 11 Feb 2025.

    Copyright: © 2025 HAN, Rubio-Alarcon, Allen, Lee and Rahman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Marcos Rubio-Alarcon, University of Cambridge, Cambridge, United Kingdom
    Thomas Allen, University of Cambridge, Cambridge, United Kingdom
    Sunwoo Lee, University of Cambridge, Cambridge, United Kingdom
    Taufiq Rahman, University of Cambridge, Cambridge, United Kingdom

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more